Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

K-Ras and sensitivity to EGFR inhibitors in metastatic colorectal cancer.

Clinical advances in hematology & oncology : H&O - 1 Mar 2008

Eng Cathy

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antibodies, Monoclonal, Humanized
Share to Cetuximab
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, ras

Share to Immunologic Factors

Share to Neoplasm Metastasis

Share to Panitumumab

Source

Identifiers

PMID: 18391915

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

K-Ras and sensitivity to EGFR inhibitors in metastatic colorectal cancer.PMID 18391915Read ↗

KRAS mutations and epidermal growth factor receptor inhibitor therapy in metastatic colorectal cancer.Semantic proximity Read ↗

Ras in digestive oncology: from molecular biology to clinical implications.Semantic proximity Read ↗

K-ras mutations in colorectal cancer: a practice changing discovery.Semantic proximity Read ↗

KRAS status predicts response to cetuximab for metastatic colorectal cancer.Semantic proximity Read ↗

Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer.Semantic proximity Read ↗

Assessment of K-ras mutation: a step toward personalized medicine for patients with colorectal cancer.Semantic proximity Read ↗

KRAS mutations in primary and metastatic colorectal cancer.Semantic proximity Read ↗

Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer.Semantic proximity Read ↗

Prognostic significance of K-ras mutations in colorectal carcinomaSemantic proximity Read ↗

K-ras mutation in colorectal cancer: relations to patient age, sex and tumour locationSemantic proximity Read ↗

Ras mutational status is a biomarker for resistance to EGFR inhibitors in colorectal carcinoma.Semantic proximity Read ↗

HER2 Amplification and Cetuximab Efficacy in Patients With Metastatic Colorectal Cancer Harboring Wild-type RAS and BRAFSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.